The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease ...
For some people with high cholesterol, making lifestyle changes and taking routine cholesterol-lowering statin medications ...
Merck's enlicitide pill lowered LDL cholesterol by up to 60%, matching injectables like Repatha and offering an easier option ...
The 72-week multinational phase 3 ATTAIN-2 trial randomized 1613 participants with obesity or overweight (BMI ≥ 27.0) and T2D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results